With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.19064-67-6,6-Chloro-3-hydroxypyridazine,as a common compound, the synthetic route is as follows.
Step A 6-(2,4-Dichloro-phenylsulfanyl)-2H-pyridazin-3-one. Potassium t-butoxide (1.1 g) was added to a solution of 2,4-dichlorothiophenol (1.8 g) in N,N-dimethylformamide (DMF) (5 mL). The mixture was stirred at room temperature for 10 minutes and then 6-chloro-2H-pyridazin-3-one (1.31 g) was added. The reaction mixture was stirred at 100 C for five hours. The mixture was then cooled to room temperature, poured into water (20 mL) and 20% potassium hydroxide (5 mL) was added. The resulting dark solution was extracted with ethyl acetate (2X10 mL). The aqueous layer was collected and the pH was adjusted to 3 with concentrated hydrochloric acid. The solutionwas then extracted with ethyl acetate (3X10 mL). The ethyl acetate layer was collected, dried over anhydrous sodium sulfate, filtered and evaporated to obtain a crude product, which was purified by silica gel chromatography (1:1 ethyl acetate/hexane as eluent) to afford 6-(2,4-dichloro-phenylsulfanyl)-2H-pyridazin-3-one (418 mg, 15%); NMR 6.88 (d,1H), 7.10 (d, 1H), 7.24(dd,1H), 7.48 (d,1H), 7.52 (d,1H).
19064-67-6, The synthetic route of 19064-67-6 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; Pfizer Products Inc.; EP1260224; (2002); A1;,
Pyridazine – Wikipedia
Pyridazine | C4H4N2 – PubChem